DOW Jones drops despite broader rally, as healthcare stocks tank on Trump’s order
DOW Jones lost 178 points, dragged down by reduced profit expectations from major U.S. healthcare firms.
Stock markets are rallying thanks to the China-U.S. tariff de-escalation, but the DOW Jones is still lagging. On Tuesday, May 13, the S&P 500 was at 5,893 points, up 50 points or 0.85%, entering positive territory for the year of 2025. The tech-focused Nasdaq was trading at 21,222.80, up 354.652 points or 1.7%.
At the same time, DOW Jones was at 42,250.67 points, down 159.43 or 0.38%. This is despite the fact that positive developments in U.S.-China trade relations boosted tech stocks. For instance, Nvidia was up 5.79%, Amazon was up 1.64%, while IBM gained 1.87%.
DOW Jones Industrial Average heat map | Source: Tipranks
Healthcare stocks hammered by Trump’s new move
Still, gains from Nvidia and Amazon were outweighed by Microsoft’s loss of 0.28%, as well as significant losses from healthcare firms. For instance, Johnson & Johnson lost 3.04%, while Merck lost 3.18%, both companies involved in healthcare.
What is more, UnitedHealth lost an astonishing 16.34% after an abrupt exit by its long-time CEO, Andrew Witty. The company also suspended its annual price forecast, citing rising medical costs for the decision.
Health care stocks have been on the decline after U.S. President Donald Trump signed an executive order aimed at slashing prescription drug prices. The administration directed companies to cut drug prices to similar levels to what patients in other countries are paying. For those that don’t comply, the White House has threatened escalating, yet unspecified measures to keep them in line.
Analysts estimated that cutting drug prices in the U.S. could cut 2028 net income for the world’s pharmaceutical industry by 8%. Still, while the move would cut into the profits of healthcare firms, it might bring relief to Americans struggling with rising healthcare costs.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
GeeFi’s Practical Ecosystem Challenges Avalanche’s Speculative Ambitions
- Avalanche (AVAX) fell to $14.94, with short-term volatility and long-term $326/2031 forecasts, contrasting GeeFi (GEE)'s $0.05 presale surge. - GeeFi's $300K+ presale (6.2M tokens sold) highlights its 3,900% ROI potential via a multi-chain wallet and 55% APR staking. - GEE's deflationary model and real-world crypto tools (DEX, spending card) challenge AVAX's speculative reliance on network upgrades. - With 80% Phase 1 completion and 700+ investors, GeeFi's urgency contrasts Avalanche's stagnant $13–$14 s
PENGU Token's Technical Surge and Changing Market Sentiment: A Brief Momentum Opportunity Among Altcoins
- PENGU Token offers high-risk, high-reward potential for short-term momentum traders, driven by technical indicators and ecosystem growth. - Structural risks like regulatory uncertainty and declining NFT demand pose significant challenges to its volatility-driven strategy. - Traders are advised to use tight stop-loss orders and position sizing, treating PENGU as a speculative, short-term play. - The upcoming Cboe ETF decision will be pivotal in determining PENGU's transition from volatile altcoin to viabl
Cardano News Today: How Getting in Early Fuels the Intense Competition in Crypto Presales
- Apeing's 2026 presale offers early access at $0.0001, targeting a 10x return as investors seek high-potential crypto opportunities amid market volatility. - Cardano (ADA) faces recovery challenges after a network split, while SUI's price surges and institutional interest highlight contrasting crypto market dynamics. - Grayscale's Zcash ETF filing and Securitize's EU tokenized securities platform signal crypto's growing institutional adoption and regulatory progress. - Analysts warn of systemic risks from
COAI Token Fraud Aftermath: Dangers and Warning Signs in New Cryptocurrency Ventures
- COAI Token's 88% collapse erased $116.8M, exposing systemic risks in algorithmic stablecoins, centralized governance, and regulatory gaps. - 87.9% token concentration in ten wallets enabled manipulation, contradicting decentralization claims while CLARITY Act ambiguities allowed regulatory exploitation. - Southeast Asia's crypto fraud hub status amplified risks, with COAI's failure mirroring FINRA-identified red flags like opaque tokenomics and anonymous teams. - Investors must prioritize technical audit
Trending news
MoreCrypto prices
More
